Cancer Gene Therapy
Leading citation impact metric from Clarivate Journal Citation Reports
80 papers with at least that number of citations each
State Council for Professorship (HĐGSNN) Scoring
Quyết định số 26/QĐ-HĐGSNN ngày 11/7/2025 (Mục quốc tế)
HĐGSNN Score History
By article publication year| Year | Max Score | Evaluation Details | Source |
|---|---|---|---|
| 2026 | 3.00đ | WoS Q1 có IF ≥ 5.0(IF: 6.4) | 🔵 Computed |
| 2025 | 3.00đ | WoS Q1 có IF ≥ 5.0(IF: 5) | 🔵 Computed |
| 2024 | 2.50đ | WoS Q1 có IF ≥ 3.0(IF: 4.8) | 🔵 Computed |
| 2023 | 3.00đ | WoS Q1 có IF ≥ 5.0(IF: 6.4) | 🔵 Computed |
| 2022 | 3.00đ | WoS Q1 có IF ≥ 5.0(IF: 5.854) | 🔵 Computed |
| 2021 | 3.00đ | WoS Q1 có IF ≥ 5.0(IF: 5.987) | 🔵 Computed |
| 2020 | 2.50đ | WoS Q1 có IF ≥ 3.0(IF: 4.534) | 🔵 Computed |
| 2019 | 2.50đ | WoS Q1 có IF ≥ 3.0(IF: 4.681) | 🔵 Computed |
| 2018 | 2.50đ | WoS Q1 có IF ≥ 3.0(IF: 4.044) | 🔵 Computed |
Note: Domestic journal scores are officially collected from annual HĐGSNN decisions across councils. International journal scores are dynamically computed according to Decision 26/QĐ-HĐGSNN based on quartile and citation metrics in the publication year.
Aims & Scope
Cancer Gene Therapy is the essential gene and cellular therapy resource for cancer researchers and clinicians, keeping readers up to date with the latest developments in gene and cellular therapies for cancer. The journal publishes original laboratory and clinical research papers, case reports and review articles. Publication topics include RNAi approaches, drug resistance, hematopoietic progenitor cell gene transfer, cancer stem cells, cellular therapies, homologous recombination, ribozyme technology, antisense technology, tumor immunotherapy and tumor suppressors, translational research, cancer therapy, gene delivery systems (viral and non-viral), anti-gene therapy (antisense, siRNA & ribozymes), apoptosis; mechanisms and therapies, vaccine development, immunology and immunotherapy, DNA synthesis and repair. Cancer Gene Therapy publishes the results of laboratory investigations, preclinical studies, and clinical trials in the field of gene transfer/gene therapy and cellular therapies as applied to cancer research. Types of articles published include original research articles; case reports; brief communications; review articles in the main fields of drug resistance/sensitivity, gene therapy, cellular therapy, tumor suppressor and anti-oncogene therapy, cytokine/tumor immunotherapy, etc.; industry perspectives; and letters to the editor.
SCImago & Scopus Journal Intelligence
Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact
Weighted prestige citation metric per document indexed in the Scopus database.
Measures cumulative publication volume and citation impact.
Average citations received per document published in the 2-year window.
Estimated Article Processing Charge for Open Access publication.
Scopus 3-Year Publication & Citation Window
Aggregated from Scopus database across the 3-year SJR evaluation window.
Societal Impact & Inclusivity (SCImago)
Citations in government and international policy documents
Percentage of female authors published in the journal
Real-world societal policy reach and author gender diversity tracked by SCImago.
Scopus Subject Categories
Chinese Academy of Sciences (CAS) Classification
Major / minor zone classification and CAS Early Warning List history
Publishing & Editorial Information
Detailed publisher, peer-review turnaround, and publication cycle specifications
WoS Categories & Quartiles
Detailed JCR / JCI category rankings and quartile breakdown from Clarivate
| Category | Index | Rank | Quartile |
|---|---|---|---|
BIOTECHNOLOGY & APPLIED MICROBIOLOGY | JCRSCIE | 27/180 | Q1 |
GENETICS & HEREDITY | JCRSCIE | 21/192 | Q1 |
MEDICINE, RESEARCH & EXPERIMENTAL | JCRSCIE | 39/191 | Q1 |
ONCOLOGY | JCRSCIE | 59/333 | Q1 |
BIOTECHNOLOGY & APPLIED MICROBIOLOGY | JCISCIE | 25/180 | Q1 |
GENETICS & HEREDITY | JCISCIE | 32/192 | Q1 |
MEDICINE, RESEARCH & EXPERIMENTAL | JCISCIE | 44/191 | Q1 |
ONCOLOGY | JCISCIE | 72/333 | Q1 |
Annual Historical Statistics & Publications
Track annual publication volume, total citations, and Impact Factor evolution
| Year | Impact Factor | Articles / Year | Total Citations |
|---|---|---|---|
| 2026 | — | 82 | 39 |
| 2025 | 5 | 130 | 507 |
| 2024 | 4.8 | 146 | 2,020 |
| 2023 | 6.4 | 140 | 2,084 |
| 2022 | 5.854 | 170 | 3,116 |
| 2021 | 5.987 | 137 | 4,134 |
| 2020 | 4.534 | 111 | 4,381 |
| 2019 | 4.681 | 87 | 2,713 |
| 2018 | 4.044 | 61 | 1,935 |
| 2017 | — | 49 | 2,055 |
| 2016 | — | 77 | 3,514 |
| 2015 | — | 80 | 2,846 |
Journal Metrics & Citation Visualizations
Impact Factor Trend (2018–2024)
Clarivate IF trend for Cancer Gene Therapy
Total Cites vs Self-Cites
Evaluation of scholarly independence and citation reach
Citations per Document
Citation metric windows across 2, 3, and 4 years
Similar Journals in Discipline
Journals in the same research field with comparable impact metrics